Carson Wealth (CWM LLC)
KYMR icon

Carson Wealth (CWM LLC)’s Kymera Therapeutics KYMR Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.5K Buy
378
+80
+27% +$6.33K ﹤0.01% 4125
2025
Q4 		$23K Buy
298
+39
+15% +$2.63K ﹤0.01% 4090
2025
Q3 		$15K Buy
259
+21
+9% +$947 ﹤0.01% 4271
2025
Q2 		$10K Sell
238
-32
-12% -$1.1K ﹤0.01% 4297
2025
Q1 		$7K Buy
270
+258
+2,150% +$9.4K ﹤0.01% 4294
2024
Q4 		$0 Sell
12
-18
-60% -$813 ﹤0.01% 5039
2024
Q3 		$1K Buy
30
+27
+900% +$1.19K ﹤0.01% 4615
2024
Q2 		$0 Hold
3
– – ﹤0.01% 4763
2024
Q1 		$0 Buy
+3
New +$107 ﹤0.01% 4535
2023
Q3 		– Sell
-12
Closed – – 4356
2023
Q2 		$0 Hold
12
– – ﹤0.01% 4326
2023
Q1 		$0 Hold
12
– – ﹤0.01% 4208
2022
Q4 		$0 Buy
+12
New +$320 ﹤0.01% 4116

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Carson Wealth (CWM LLC)'s KYMR Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Kymera Therapeutics (KYMR) stake by 27% in Q1 2026, buying an estimated $6.33K and bringing the position to 378 shares worth $31.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4125.

Carson Wealth (CWM LLC) first reported a position in KYMR in Q4 2022 and has held it in 12 quarters since. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Carson Wealth (CWM LLC) held 378 shares of Kymera Therapeutics worth $31.5K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 80 Kymera Therapeutics shares in Q1 2026, an estimated $6.33K.
  • Kymera Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4125 holding.
  • Carson Wealth (CWM LLC) first reported a position in Kymera Therapeutics in Q4 2022 and has held it in 12 quarters since.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.